185 related articles for article (PubMed ID: 9667560)
1. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.
Rand KH; Houck H; Denslow ND; Heilman KM
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):48-55. PubMed ID: 9667560
[TBL] [Abstract][Full Text] [Related]
2. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.
Rand KH; Houck H; Denslow ND; Heilman KM
J Neurol Sci; 2000 Feb; 173(1):32-9. PubMed ID: 10675577
[TBL] [Abstract][Full Text] [Related]
4. Improved methods for the application of random peptide phage libraries to the study of the oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis.
Rand KH; Houck H
J Neurosci Methods; 2000 Sep; 101(2):131-9. PubMed ID: 10996373
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
Graner M; Pointon T; Manton S; Green M; Dennison K; Davis M; Braiotta G; Craft J; Edwards T; Polonsky B; Fringuello A; Vollmer T; Yu X
PLoS One; 2020; 15(2):e0228883. PubMed ID: 32084151
[TBL] [Abstract][Full Text] [Related]
6. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C
J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244
[TBL] [Abstract][Full Text] [Related]
8. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
Mechelli R; Anderson J; Vittori D; Coarelli G; Annibali V; Cannoni S; Aloisi F; Salvetti M; James JA; Ristori G
Mult Scler; 2011 Nov; 17(11):1290-4. PubMed ID: 21757535
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
Archelos JJ; Trotter J; Previtali S; Weissbrich B; Toyka KV; Hartung HP
Ann Neurol; 1998 Jan; 43(1):15-24. PubMed ID: 9450764
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
12. Molecular immunologic strategies to identify antigens and b-cell responses unique to multiple sclerosis.
Gilden DH; Burgoon MP; Kleinschmidt-DeMasters BK; Williamson RA; Ghausi O; Burton DR; Owens GP
Arch Neurol; 2001 Jan; 58(1):43-8. PubMed ID: 11176935
[TBL] [Abstract][Full Text] [Related]
13. Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.
Kennedy PGE; Graner MW; Walker D; Pointon T; Fringuello A; Yu X
J Neuroimmunol; 2020 Oct; 347():577319. PubMed ID: 32717427
[TBL] [Abstract][Full Text] [Related]
14. An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway.
Vaughan JH; Riise T; Rhodes GH; Nguyen MD; Barrett-Connor E; Nyland H
J Neuroimmunol; 1996 Sep; 69(1-2):95-102. PubMed ID: 8823380
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of human anti-tumor necrosis factor-alpha monoclonal antibodies from Epstein-Barr virus transformed oligoclonal libraries.
Takekoshi M; Maeda F; Nagatsuka Y; Aotsuka S; Ono Y; Ihara S
J Biochem; 2001 Aug; 130(2):299-303. PubMed ID: 11481049
[TBL] [Abstract][Full Text] [Related]
16. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
[TBL] [Abstract][Full Text] [Related]
17. Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen.
Cook AD; Davies JM; Myers MA; Mackay IR; Rowley MJ
J Autoimmun; 1998 Jun; 11(3):205-11. PubMed ID: 9693968
[TBL] [Abstract][Full Text] [Related]
18. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens.
Yao SY; Stratton CW; Mitchell WM; Sriram S
Neurology; 2001 May; 56(9):1168-76. PubMed ID: 11342681
[TBL] [Abstract][Full Text] [Related]
19. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
[TBL] [Abstract][Full Text] [Related]
20. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
